Page 3,460«..1020..3,4593,4603,4613,462..3,4703,480..»

Soft Tissue Sarcoma

Posted: Published on October 9th, 2014

Laurent Levy, CEO of Nanobiotix said: "As planned, we should start the pivotal phase before the end of the year, the association of PharmaEngine to the trial is an excellent news. This reinforced collaboration will allow us to pool resources and data leading to a more impactful study for this first key indication. Moreover PharmaEngine's direct collaboration to the last phase of development of NBTXR3 is a new plan that should allow a faster access to the Asian market." Soft Tissue Sarcoma Following the very positive pilot Phase I results for advanced soft tissue sarcoma (STS) recently presented at the American Society of Clinical Oncology (ASCO) annual meeting, PharmaEngine and Nanobiotix have decided to accelerate the clinical development of NBTXR3 in the Asia-Pacific region. The planned European pivotal trial for NBTXR3 in soft tissue sarcoma will be broadened to Asia-Pacific where PharmaEngine will open additional clinical centers in multiple countries. Nanobiotix is sponsoring the global trial and PharmaEngine is co-sponsoring for the Asia-Pacific territory. The partners will bear the costs of the trial in their respective territories. The expanded soft tissue sarcoma trial will provide additional clinical centers in multiples countries in Asia-Pacific, a larger cohort of enrolled patients and … Continue reading

Comments Off on Soft Tissue Sarcoma

BCLI Gets A Pat On The Back, OXGN At Work, MDGN Rises After Hours

Posted: Published on October 9th, 2014

BrainStorm Cell Therapeutics Inc. (BCLI: Quote) has secured FDA's Fast Track product designation for its core technology, NurOwn, which is currently being studied in a randomized, double-blind, placebo-controlled phase II clinical trial in amyotrophic lateral sclerosis patients. The NurOwn technology processes adult human mesenchymal stem cells that are present in bone marrow and are capable of self-renewal as well as differentiation into many other cell types. BCLI closed Tuesday's trading at $3.98, up 2.84%. OXiGENE Inc. (OXGN: Quote) has enrolled the first patient in a phase 1b/2 clinical study that will evaluate its drug candidate Fosbretabulin in combination with GlaxoSmithKline PLC's (GSK) approved cancer medication Votrient in patients with recurrent ovarian cancer. The study is estimated to enroll up to 128 patients at sites in the United Kingdom. The primary endpoint is progression-free survival, and secondary endpoints include safety, overall survival, objective response rate and relevant biomarkers. OXGN closed Tuesday's trading 6.88% higher at $2.33. Medgenics Inc. (MDGN: Quote) is all set to present initial data from its ongoing phase 1/2 clinical trial of MDGN-201 at the 22nd Annual Congress of the European Society of Gene and Cell Therapy being held in The Hague, Netherlands from October 23rd-26th, 2014. The … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on BCLI Gets A Pat On The Back, OXGN At Work, MDGN Rises After Hours

Rob's Stem Cell Transplant – Video

Posted: Published on October 9th, 2014

Rob's Stem Cell Transplant Description. By: Sharon Minton … Continue reading

Posted in Stem Cell Transplant | Comments Off on Rob's Stem Cell Transplant – Video

Dr. Z. Paul Lorenc – Aesthetic Surgery NYC – Video

Posted: Published on October 9th, 2014

Dr. Z. Paul Lorenc - Aesthetic Surgery NYC http://www.lorenc.com/ Dr. Z. Paul Lorenc, director of Lorenc Aesthetic Surgery in New York City, is one of the chief pioneers in plastic surgery and cosmeti... By: Dr. Paul Lorenc … Continue reading

Posted in Aesthetic Surgery | Comments Off on Dr. Z. Paul Lorenc – Aesthetic Surgery NYC – Video

Stem Cell Treatment for SCI Documentary Part 5 – Video

Posted: Published on October 9th, 2014

Stem Cell Treatment for SCI Documentary Part 5 via YouTube Capture. By: frnkmckenzie … Continue reading

Comments Off on Stem Cell Treatment for SCI Documentary Part 5 – Video

BrainStorm : FDA Grants Fast Track Designation To NurOwn For Treatment Of ALS

Posted: Published on October 9th, 2014

By RTT News, October 07, 2014, 07:19:00 AM EDT (RTTNews.com) - BrainStorm Cell Therapeutics Inc. ( BCLI ), a developer of adult stem cell technologies for neurodegenerative diseases, said that the United States Food and Drug Administration or FDA has designated NurOwn as a Fast Track product for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's Disease). NurOwn consists of autologous mesenchymal stem cells that have been induced to secrete neurotrophic factors, and is currently being studied in a randomized, double-blind, placebo-controlled phase 2 clinical trial in ALS patients. "We are pleased that the FDA has granted Fast Track status for NurOwn as this will allow us greater and more frequent dialogue with the Agency as we continue the development of this ground-breaking cell therapy for the treatment of ALS," said Tony Fiorino, Chief Executive Officer of BrainStorm. For comments and feedback: contact editorial@rttnews.com http://www.rttnews.com Read the original post: BrainStorm : FDA Grants Fast Track Designation To NurOwn For Treatment Of ALS … Continue reading

Comments Off on BrainStorm : FDA Grants Fast Track Designation To NurOwn For Treatment Of ALS

IVF Treatment by Dr. S.P.S. Virk – Video

Posted: Published on October 8th, 2014

IVF Treatment by Dr. S.P.S. Virk Virk Fertility Services led by Dr. S.P.S.Virk in jalandhar.This is the first IVF centre in India to be accredited by NABH Safe-I. Virk Fertility Services led... By: VFS Jalandhar … Continue reading

Posted in IVF Treatment | Comments Off on IVF Treatment by Dr. S.P.S. Virk – Video

Councillors vote to halve free IVF treatment available to Black Country couples

Posted: Published on October 8th, 2014

Sandwell councillors have voted to halve the number of free IVF cycles available on the NHS in the Black Country. Just one free cycle will now be offered in Sandwell, bringing the area into line with Birmingham. Councillors voted to impose the cut, to come into force in May 2016, after health chiefs said it was not a priority. That guidance contradicted research which showed almost half of patients, the public and health professionals wanted cycle numbers increased rather than reduced. Andrew Willians, of the Sandwell and West Birmingham Clinical Commissioning Group, said: The guidance we have been given is that we should not be committing to more than one cycle. We should prioritise supporting people returning from hospital to live independently. It is the right thing to do. But Coun Bob Lloyd (Lab, Wednesbury South), an opponent of the cuts proposal, told a Sandwell Council health scrutiny meeting: I think we should be raising the standard to Birmingham, not lowering it. When women were getting paid less than men, we didnt decide to pay men less we raised the womans wage. It is giving less to more. Read the original post: Councillors vote to halve free IVF treatment available … Continue reading

Posted in IVF Treatment | Comments Off on Councillors vote to halve free IVF treatment available to Black Country couples

Researchers develop reproducibility score for SNPs associated with human disease in GWAS

Posted: Published on October 8th, 2014

PUBLIC RELEASE DATE: 8-Oct-2014 Contact: Robin Dutcher robin.Dutcher@hitchcock.org 603-653-9056 The Geisel School of Medicine at Dartmouth Lebanon, NH, 10/8/14 To reduce false positives when identifying genetic variations associated with human disease through genome-wide association studies (GWAS), Dartmouth researchers have identified nine traits that are not dependent on P values to predict single nucleotide polymorphisms (SNP) reproducibility as reported in Human Genetics on October 2, 2014. Reproducibility rates of SNPs based solely on P values is low. Dartmouth authors' analysis of GWAS studies published in Nature Genetics showed a 1-5 percent replication rate. "It is important to improve our ability to select SNPs for validation using a formalized process. In this paper, we propose a combination of traits that improve replication success," said first author Ivan P. Gorlov, PhD, DSC, associate professor of Community and Family Medicine, Geisel School of Medicine at Dartmouth. The team assigned a value of zero or one to nine different predictors. To compute the Replication Score (RS), one totals the individual scores for all significant predictors. The predictors include "Online Mendelian Inheritance in Man" (OMIM, a list of genetically caused diseases), receptors, kinases, growth factors, transcription factors, tissue specific, plasma membrane localization, nuclear localization and conversation … Continue reading

Posted in Human Genetics | Comments Off on Researchers develop reproducibility score for SNPs associated with human disease in GWAS

Dartmouth Researchers Develop Reproducibility Score for SNPs Associated with Human Disease in GWAS

Posted: Published on October 8th, 2014

Contact Information Available for logged-in reporters only Newswise To reduce false positives when identifying genetic variations associated with human disease through genome-wide association studies (GWAS), Dartmouth researchers have identified nine traits that are not dependent on P values to predict single nucleotide polymorphisms (SNP) reproducibility as reported in Human Genetics on October 2, 2014. Reproducibility rates of SNPs based solely on P values is low. Dartmouth authors analysis of GWAS studies published in Nature Genetics showed a 1-5 percent replication rate. It is important to improve our ability to select SNPs for validation using a formalized process. In this paper, we propose a combination of traits that improve replication success, said first author Ivan P. Gorlov, PhD, DSC, associate professor of Community and Family Medicine, Geisel School of Medicine at Dartmouth. The team assigned a value of zero or one to nine different predictors. To compute the Replication Score (RS), one totals the individual scores for all significant predictors. The predictors include Online Mendelian Inheritance in Man (OMIM, a list of genetically caused diseases), receptors, kinases, growth factors, transcription factors, tissue specific, plasma membrane localization, nuclear localization and conversation index. The authors provided detailed information to construct the RS in … Continue reading

Posted in Human Genetics | Comments Off on Dartmouth Researchers Develop Reproducibility Score for SNPs Associated with Human Disease in GWAS

Page 3,460«..1020..3,4593,4603,4613,462..3,4703,480..»